|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
Morphic Holding, Inc. (MORF) |
|
|
$56.99 0.00 (0.00%) as of 4:30 Thu 8/15
|
|
Download |
|
|
Company
Roster
|
Total
Insiders : |
16 |
|
|
Total
Direct Shares :
|
4,811,879 |
|
Total
Indirect Shares :
|
8,237,126 |
|
%
Held by Insiders:
|
9.67% |
|
|
|
Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Slattery Joseph P |
|
2024-08-16 |
0 |
2019-07-01 |
0 |
Nashat Amir |
|
2024-08-16 |
0 |
2024-08-16 |
0 |
Devaul William |
|
2024-08-16 |
0 |
2020-07-01 |
0 |
Springer Timothy A |
|
2024-08-16 |
0 |
2024-08-16 |
0 |
Schegerin Marc |
|
2024-08-16 |
0 |
|
0 |
Rogers Bruce |
|
2024-08-16 |
0 |
|
0 |
Edwards Martin |
|
2024-08-16 |
0 |
2023-11-13 |
0 |
Farrell Robert E Jr |
|
2024-08-16 |
0 |
|
0 |
Christensen Gustav |
|
2024-08-16 |
0 |
|
0 |
Tipirneni Praveen P. |
|
2024-08-16 |
0 |
2024-08-16 |
0 |
Linde Peter |
Chief Medical Officer |
2021-09-16 |
11,272 |
2021-03-16 |
0 |
Stampacchia Otello |
Director |
2021-04-30 |
2,068,913 |
2019-07-01 |
2,969,582 |
Goyal Vikas |
Director |
2021-03-05 |
1,000 |
2019-07-01 |
2,633,772 |
Lugovskoy Alexey |
Chief Development Officer |
2020-11-10 |
85,248 |
|
0 |
Glaxosmithkline Plc |
Director |
2019-07-01 |
0 |
2019-07-01 |
2,633,772 |
Novo A/s |
10% Owner |
2019-06-28 |
2,645,446 |
2019-06-28 |
0 |
|
|